Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Avista to Acquire Miraca Life Sciences

Posted in Life Sciences Investing

Avista Capital Partners will acquire Miraca Life Sciences from Miraca Holdings, according to a news release.

Miraca Life Sciences, based in Irving, Texas, is a national, independent anatomic pathology lab providing subspecialty anatomic pathology services in the fields of gastroenterology, dermatology, hematology, breast health and urology.

Avista, headquartered in New York, a private equity firm that makes middle-market control buyout investments in the healthcare sector. Founded in 2005, the company has approximately $6 billion under management.

Miraca Holdings is a Japan-based holding company in the healthcare sector.

Financial terms were not disclosed.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree